ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,302.57
0.27%
Dow Jones
44,287.62
0.09%
Gold vs US Dollar
2,714.87
0.71%
Brent Oil
72.93
1.38%
Bitcoin
100,795.04
4.27%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Irras Ab (0GDW)

  7. Irras Ab (0GDW) News

Irras Ab (0GDW)

Irras Ab
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0GDW
DateTimeSourceHeadlineSymbolCompany
16/02/202307:16PR Newswire (US)IRRAS AB publishes Year End Report for the period January to December 2022LSE:0GDWIrras Ab
16/02/202307:14PR Newswire (US)IRRAS AB publishes Year End Report for the period January to December 2022LSE:0GDWIrras Ab
13/02/202308:45PR Newswire (US)IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head AnalysisLSE:0GDWIrras Ab
13/02/202308:42PR Newswire (US)IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head AnalysisLSE:0GDWIrras Ab
12/12/202207:43PR Newswire (US)IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control UnitLSE:0GDWIrras Ab
12/12/202207:40PR Newswire (US)IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control UnitLSE:0GDWIrras Ab
14/11/202217:53PR Newswire (US)IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® SystemLSE:0GDWIrras Ab
14/11/202217:33PR Newswire (US)IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® SystemLSE:0GDWIrras Ab
10/11/202207:32PR Newswire (US)IRRAS AB publishes Interim Report for the period January to September 2022LSE:0GDWIrras Ab
10/11/202207:30PR Newswire (US)IRRAS AB publishes Interim Report for the period January to September 2022LSE:0GDWIrras Ab
13/10/202206:55PR Newswire (US)IRRAS Announces Participation and Data Presentation at the 22nd European Congress of NeurosurgeryLSE:0GDWIrras Ab
13/10/202206:54PR Newswire (US)IRRAS Announces Participation and Data Presentation at the 22nd European Congress of NeurosurgeryLSE:0GDWIrras Ab
11/10/202206:43PR Newswire (US)IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of NeurosurgeryLSE:0GDWIrras Ab
11/10/202206:41PR Newswire (US)IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of NeurosurgeryLSE:0GDWIrras Ab
05/10/202207:09PR Newswire (US)IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery ConferencesLSE:0GDWIrras Ab
05/10/202207:07PR Newswire (US)IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery ConferencesLSE:0GDWIrras Ab
23/08/202206:46PR Newswire (US)IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE StudyLSE:0GDWIrras Ab
23/08/202206:44PR Newswire (US)IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE StudyLSE:0GDWIrras Ab
22/07/202206:21PR Newswire (US)IRRAS AB publishes Interim Report for the period January to June 2022LSE:0GDWIrras Ab
22/07/202206:18PR Newswire (US)IRRAS AB publishes Interim Report for the period January to June 2022LSE:0GDWIrras Ab
28/05/202106:45PR Newswire (US)IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow...LSE:0GDWIrras Ab
28/05/202106:43PR Newswire (US)IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow...LSE:0GDWIrras Ab
11/05/202106:54PR Newswire (US)IRRAS Announces Notified Body Transition from GMED to DEKRA, a Global Leader in Inspection and CertificationsLSE:0GDWIrras Ab
11/05/202106:52PR Newswire (US)IRRAS Announces Notified Body Transition from GMED to DEKRA, a Global Leader in Inspection and CertificationsLSE:0GDWIrras Ab
04/05/202106:21PR Newswire (US)IRRAS AB publishes Interim Report for the period January to March 2021LSE:0GDWIrras Ab
04/05/202106:18PR Newswire (US)IRRAS AB publishes Interim Report for the period January to March 2021LSE:0GDWIrras Ab
21/04/202118:09PR Newswire (US)IRRAS Promotes Will Martin to Chief Executive OfficerLSE:0GDWIrras Ab
21/04/202118:07PR Newswire (US)IRRAS Promotes Will Martin to Chief Executive OfficerLSE:0GDWIrras Ab
06/04/202106:48PR Newswire (US)IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflo...LSE:0GDWIrras Ab
06/04/202106:46PR Newswire (US)IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflo...LSE:0GDWIrras Ab
 Showing the most relevant articles for your search:LSE:0GDW

Your Recent History

LSE
PANR
Pantheon Resources
LSE
SBTX
Skinbiotherapeutics
LSE
VAST
Vast Resources
LSE
GEX
Georgina Energy
LSE
POS
Plexus
LSE
SYME
Supply@me Capital
LSE
THG
Thg
LSE
HVO
Hvivo
LSE
LLOY
Lloyds Banking
LSE
ALTN
Altyngold
LSE
EQLS
Equals
LSE
BOO
Boohoo
LSE
AXL
Arrow Exploration
LSE
GKP
Gulf Keystone Petroleum
LSE
OMI
Orosur Mining
LSE
TERN
Tern
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved